US Pharma MarketingChutes & Ladders—Allogene swaps in CMO as new chief exec
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. After more than eight years at the helm of off-the-shelf CAR-T company Allogene Therapeutics, co-founder David Chang, M.D., Ph.D., is stepping down so that Zachary Roberts, M.D., Ph.D., the biotech’s chief medical officer and head of R&D, can take his place starting June 30. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research &…
After more than eight years at the helm of off-the-shelf CAR-T company Allogene Therapeutics, co-founder David Chang, M.D., Ph.D., is stepping down so that Zachary Roberts, M.D., Ph.D., the biotech’s chief medical officer and head of R&D, can take his place starting June 30.
Source: FierceBiotech